Transcription Factor YY1 Drives Radiotherapy Resistance in Lung Adenocarcinoma Through PMVK
A study reveals that the transcription factor YY1 transcriptionally activates PMVK to suppress ferroptosis and promote radiotherapy resistance in lung ...
A study reveals that the transcription factor YY1 transcriptionally activates PMVK to suppress ferroptosis and promote radiotherapy resistance in lung ...
Researchers have identified that loss of hypoxia-inducible factor 1-alpha under normoxic conditions drives serine and glycine metabolism to promote radiotherapy ...
A new study reports that irradiation stabilizes EZH2 in glioblastoma, driving H3K27me3-mediated DEPTOR repression and mTOR activation, and that EZH2 ...
In a groundbreaking study soon to be published in the Journal of Translational Medicine, researchers have unveiled compelling evidence that ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.